Day: May 2, 2024

The council of Nordecon AS has adopted a decision to appoint Maret Tambek as the chairman of the company’s management board from 01 May 2024 with the term of office of three years. From 08 January 2024, Maret Tambek acted as acting chairman of the management board of Nordecon AS. The management board of Nordecon AS will continue with three members: Maret Tambek (chairman), Tarmo Pohlak and Priit Luman. Nordecon (www.nordecon.com) is a group of construction companies whose core business is construction project management and general contracting in the buildings and infrastructures segment. Geographically the Group operates in Estonia, Ukraine and Sweden. The parent of the Group is Nordecon AS, a company registered and located in Tallinn, Estonia. The consolidated revenue of the Group in 2023 was 278 million euros. Currently Nordecon...

Amsterdam 2 May 2024, 8 AM CET. Cabka N.V. (together with its subsidiaries “Cabka”, or the “Company”), a company specialized in transforming hard to recycle plastic waste into innovative Reusable Transport Packaging (RTP), listed at Euronext Amsterdam, announces that its Supervisory Board will nominate Alexander Masharov (1980) for appointment by the shareholders of Cabka as member of the Management Board and Chief Executive Officer. If appointed, Alexander will succeed Tim Litjens, who announced in March 2024 his intention to step down and leave Cabka by the end of the third quarter 2024. An Extraordinary General Meeting of Shareholders shall be convened in due course to resolve on the appointment. If appointed, Alexander Masharov will join Cabka NV as of 1 August 2024 to allow for a seamless CEO succession. Cabka’s strategic goals remain...

Alm. Brand Group upgrades guidance for pre-tax profit by DKK 100 millionAlm. Brand Group’s insurance service result was a profit of DKK 295 million (Q1 2023: DKK 205 million), driven in particular by sustained favourable trends in Commercial Lines Insurance revenue grew at a highly satisfactory rate of 5.6% to DKK 3,012 million (Q1 2023: DKK 2,853 million), driven in particular by strong growth of 8.6% in Personal Lines The underlying claims experience improved by 3.0 percentage points to 61.0, driven by a strong performance in Commercial Lines and favourable developments in Personal Lines despite a sustained high frequency of motor claims The implementation of synergy initiatives is progressing according to plan and generated a positive accounting effect of DKK 98 million in Q1 2024. The expense ratio was 19.1 (Q1 2023: 20.0) Highly...

PDUFA Target Action Date of June 26, 2024 Eight posters including two oral presentations support potential of ensifentrine,an investigational, first-in-class, selective, dual inhibitor of PDE3 and PDE4 LONDON and RALEIGH, N.C., May 02, 2024 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), announces eight posters, including two mini oral symposia, on additional analyses from its successful Phase 3 ENHANCE studies with ensifentrine for the treatment of chronic obstructive pulmonary disease (“COPD”) will be presented at the American Thoracic Society International Conference (“ATS”) 2024. Pooled analysis demonstrating reductions in the rate and risk of exacerbations with ensifentrine will be presented as part of the ‘Late Breaking Mini Symposium’ designed to highlight new breakthroughs. The posters...

Miko Niinemäe, Chairman of the Board at Arco Vara is to leave the company, and the Supervisory Board has begun searching for a new board member, who will take over the leadership by the end of the year at the latest. Miko Niinemäe, who joined Arco Vara in 2017 and was elected as the company’s CEO in 2020, said he can leave with peace of mind. “Seven years in one organization is quite a long period these days. Starting as the youngest manager of a listed company on the Tallinn Stock Exchange, a career turn at some point is quite expected. I felt that this moment has now arrived,” explained Niinemäe. According to Tarmo Sild, the Chairman of the Supervisory Board at Arco Vara, Niinemäe’s desire to resign and try something else is understandable, as he has successfully proven himself in real estate development. “On...

ENDEAVOUR REPORTS Q1-2024 RESULTSOn track for 2024 guidance • BIOX® Expansion first gold achieved • Lafigué dry commissioning underwayOPERATIONAL AND FINANCIAL HIGHLIGHTS (for continuing operations unless otherwise specified)Q1-2024 production of 219koz at an AISC of $1,186/oz; on track to achieve full year 2024 guidance with performance strongly weighted towards H2-2024Adjusted EBITDA of $213m for Q1-2024, down 27% over Q4-2023Adjusted Net Earnings of $41m (or $0.17/sh) for Q1-2024, flat over Q4-2023Operating Cash Flow before changes in WC of $137m (or $0.56/sh) for Q1-2024, down 44% over Q4-2023Healthy financial position with a net debt position of $831m at end Q1-2024 with $481m in cash and available liquidityORGANIC GROWTHSabodala-Massawa BIOX® Expansion first gold pour completed on...

Enefit Green group’s operating income for Q1 2024 decreased by 11% while operating expenses for the period decreased by 22% compared to the same period last year. As a result, EBITDA increased by 3% to €42.4m and net profit for the quarter increased by 10% to €33.4m (earnings per share €0.13). Aavo Kärmas, Chairman of the management Board of Enefit Green comments: “We produced 494 gigawatt-hours of electricity (+22%) and 129 gigawatt-hours of thermal energy (-27%). The increase in electricity production by a fifth was driven by newly completed wind and solar farms and those under construction (+131 gigawatt-hours). The decrease in heat output was mainly due to the sale of biomass assets. We focused on the completion of wind and solar farms under construction and invested nearly 105 million euros. We completed construction works at Tolpanvaara...